Long-term efficacy of erenumab in patients with episodic migraine who have failed prior preventive migraine therapies

被引：0
|
作者：
Reuter, U.
Schwedt, T. [1 ]
Kudrow, D. [2 ]
Paemeleire, K.
Zhang, F. [3 ]
Klatt, J.
Picard, H.
Chou, D. [3 ]
Mikol, D. D. [3 ]
机构：
[1] Mayo Clin Arizona, Phoenix, AZ USA
[2] Calif Med Clin Headache, Santa Monica, CA USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO2148
引用
收藏
页码：637 / 637
页数：1
相关论文
共 50 条
  • [1] Long-term Efficacy of Erenumab in Patients With Episodic Migranie Who Have Failed Prior Preventive Migraine Therapies
    Reuter, Uwe
    Schwedt, Todd J.
    Kudrow, David
    Paemeleire, Koen
    Zhang, Feng
    Klatt, Jan
    Picard, Hernan
    Chou, Denise E.
    Mikol, Daniel D.
    NEUROLOGY, 2019, 92 (15)
  • [2] Long-term efficacy of erenumab in patients with chronic migraine who failed prior prophylactic treatment
    Ashina, Messoud
    Tepper, Stewart J.
    Brandes, Jan L.
    Reuter, Uwe
    Boudreau, Guy
    Dolezil, David
    Klatt, Jan
    Zhang, Feng
    Cheng, Sunfa
    Mikol, Daniel D.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [3] Long-term Efficacy of Erenumab in Patients with Chronic Migraine Who Failed Prior Prophylactic Treatment
    Ashina, M.
    Tepper, S. J.
    Brandes, J.
    Boudreau, G.
    Dolezil, D.
    Klatt, J.
    Zhang, F.
    Cheng, S.
    Mikol, D. D.
    HEADACHE, 2018, 58 (08): : 1296 - 1297
  • [4] Long-term Efficacy of Erenumab in Patients With Chronic Migraine Who Failed ≥3 Prior Prophylactic Treatments
    Weatherall, Mark
    Gantenbein, Andreas R.
    Ritter, Shannon
    Snellman, Josefin
    Klatt, Jan
    Mikol, Daniel D.
    CEPHALALGIA, 2019, 39 : 240 - 241
  • [5] INDIRECT COMPARISON OF THE EFFICACY OF FREMANEZUMAB VERSUS ERENUMAB IN EPISODIC MIGRAINE PATIENTS WHO HAD FAILED 2-4 PRIOR MIGRAINE PREVENTIVE TREATMENTS
    Patterson-Lomba, O.
    Thompson, S.
    Gandhi, S. K.
    Yang, R.
    Cohen, J.
    Mu, F.
    Young, J.
    VALUE IN HEALTH, 2019, 22 : S737 - S737
  • [6] Efficacy of fremanezumab in migraine patients who have failed at least one prior migraine preventive medication
    McAllister, Peter
    Dodick, David W.
    Cohen, Joshua M.
    Yang, Ronghua
    Yeung, Paul P.
    Ramirez Campos, Verena
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [7] Efficacy of Fremanezumab in Migraine Patients Who Have Failed at Least One Prior Migraine Preventive Medication
    McAllister, Peter
    Dodick, David
    Cohen, Joshua
    Yang, Ronghua
    Yeung, Paul
    Campos, Verena Ramirez
    NEUROLOGY, 2019, 92 (15)
  • [8] Long-Term Efficacy of Fremanezumab in Chronic and Episodic Migraine Patients Who Failed at Least One Prior Migraine Preventive Medication: Results of a 1-Year Study
    Winner, P. K.
    Freeman, M. C.
    Cohen, J. M.
    Yang, R.
    Ning, X.
    HEADACHE, 2019, 59 : 118 - 119
  • [9] Long-term efficacy of fremanezumab in chronic and episodic migraine patients who failed at least one prior migraine preventive medication: results of a 1-year study
    Winner, Paul K.
    Freeman, Marshall C.
    Cohen, Joshua M.
    Yang, Ronghua
    Ning, Xiaoping
    Blaiss, Cory
    CEPHALALGIA, 2019, 39 : 36 - 37
  • [10] Long-Term Efficacy of Fremanezumab in Chronic and Episodic Migraine Patients Who Failed at Least One Prior Migraine Preventive Medication: Results of a 1-Year Study
    Winner, Paul K.
    Freeman, Marshall C.
    Cohen, Joshua M.
    Yang, Ronghua
    Ning, Xiaoping
    Ortega, Mario
    ANNALS OF NEUROLOGY, 2019, 86 : S168 - S169
12345